Form 4: Entera Bio Director Sean Ellis Acquires and Disposes of Shares in Recent Transaction
SEC Form 4 Filing
Director Sean Ellis reports acquiring and disposing of Entera Bio shares on August 27, 2024.
Summary
- On August 27, 2024, Sean Ellis, a director of Entera Bio Ltd., engaged in a transaction involving the company's ordinary shares.
- Ellis acquired 18,061 ordinary shares at a price of $0.
- Simultaneously, Ellis disposed of 120,161 ordinary shares.
- Following these transactions, the reported beneficial ownership of ordinary shares is not explicitly stated in the provided document.
Sentiment
Score: 5
Explanation: This is a neutral report of a transaction. The sentiment is neither positive nor negative as it simply reflects the required disclosure of a director's share activity.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, like directors, who trade in their company's stock. It provides transparency to the market regarding the transactions of those with privileged information.
Stakeholder Impact
- Shareholders are informed about the trading activities of a company director, contributing to market transparency.
Key Dates
| Date | Description |
|---|---|
| 08/27/2024 | Date of the share acquisition and disposal transaction. |
| 08/29/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.